Pharmacology

Drug Development Drug Mechanisms Psychoactive Substances Drug Research Psychedelics GLP-1 Agonists Drug Effects Drug Safety Hormones Drug Effectiveness Psychedelic Substances Gut Hormones Emergency Contraceptives Medicinal Claims Medical Gases Hormonal Treatments Performance-Enhancing Drugs Xylazine Veterinary Medicine Mifepristone Ruling Applied Physical Sciences Psychedelic Drugs Drug Classification GLP-1 Receptor Agonists Anesthetic Drugs Opioids Anabolic Steroids Psychoactive Compounds Drug Mechanism Natural Products Therapeutics Cannabinoids Psychedelic Therapy

Elon Musk's Ketamine Use Raises Questions About Mental Health and Leadership

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

GLP-1 Weight Loss Drugs Surge in Popularity Amidst Stigma and Cultural Shifts

Chinese Zoo Faces Backlash for Selling Tiger Urine as Arthritis Remedy

Growing Demand for Weight-Loss Drugs in the UK Raises Safety and Accessibility Concerns

Merck Secures $2 Billion Deal for Experimental Oral Weight Loss Drug from Hansoh Pharma

VA Launches First Psychedelic Therapy Study in Over 50 Years to Address PTSD in Veterans

NHS Rolls Out Varenicline to Help Smokers Quit

Cannabinol Found to Enhance Sleep Quality in New Study

Limited Access to Popular Weight-Loss Drugs Highlights Socioeconomic Disparities

Eli Lilly Fights Back Against Compounded Tirzepatide Amid FDA Supply Resolution

Organon Acquires Dermavant from Roivant for Up to $1.2 Billion

Kourtney Kardashian Launches Controversial GLP-1 Supplement

Weight Loss Drug Liraglutide Shows Promise for Children as Young as Six

New Study Fuels Debate on Semaglutide's Mental Health Risks